Prophylactic treatment for preeclampsia in high-risk teenage primigravidae with nitric oxide donors: a pilot study.

Autor:	Abdel Razik, Mohamed, El-Berry, Seham, Abosereah, Mahmoud, Edris, Yehia, Sharafeldeen, Amrr
Předmět:	PREECLAMPSIA NITRIC oxide PREVENTIVE medicine HIGH-risk pregnancy UTERINE artery PREECLAMPSIA prevention CARDIOVASCULAR agents COMPARATIVE studies FETAL growth retardation FETAL ultrasonic imaging GESTATIONAL age PREMATURE infants RESEARCH methodology EVALUATION of medical care MEDICAL cooperation NEONATAL intensive care PLACEBOS PREGNANCY RESEARCH TEENAGE pregnancy PILOT projects EVALUATION research RANDOMIZED controlled trials REPRODUCTIVE history PREVENTION THERAPEUTICS
Zdroj:	Journal of Maternal-Fetal & Neonatal Medicine; Aug2016, Vol. 29 Issue 16, p2617-2620, 4p
Abstrakt:	Objectives: Preeclampsia is associated with significant morbidity and mortality especially in high-risk groups. Impairment of endogenous nitric oxide has been shown to be associated with the disease and prophylactic therapy may ameliorate this condition and improve pregnancy outcome. This study valuated nitric oxide donors prophylactic treatment for preeclampsia in high-risk teenage primigravidae.Methods: The study included three hundred primigravidae aged ≤ 20 years with singleton pregnancy. Abdominal pulsed color Doppler ultrasound was done at 24 weeks gestation and pregnancies with uterine artery diastolic notch were randomly allocated to a control group received placebo vaginal tablets and a study group received isosorbid mononitrate 20 mg tablet once daily applied vaginally until delivery.Outcomes: Incidence of preeclampsia and maternal, fetal, and neonatal outcome in both groups.Results: The study group had significant lower incidence of preeclampsia, preterm birth, intrauterine growth restriction and of neonatal admission to the intensive care (p < 0.05).Conclusions: Nitric oxide donors prophylactic treatment for preeclampsia in high-risk teenage pregnancies decrease the incidence of preeclampsia and improve maternal, fetal, and neonatal outcomes. Further studies on larger sample size are required to confirm these results. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu